Tolizor caps. 150mg 30 units 1 + 1


Tolizor caps. 150mg 30 units 1 + 1



Active substance:
50 mg 1 capsule contains: tolperisone hydrochloride -50,00 mg 1 capsule 150 mg contains: mg tolperisone hydrochloride -150.00 ;.
Product form:
Capsules of 50 and 150 mg. 5, 7, 10, 20, 30 capsules in blisters of PVC film and aluminum foil printed patent.
Hypersensitivity to any component of the drug. Myasthenia gravis. Children under 18 years of age. Breast-feeding. Lactose intolerance, lactase deficiency, glucose-galactose malabsorption.
150 mg
Symptomatic treatment of spasticity in adults caused by stroke.
pharmachologic effect
Pharmacological group:
Muscle relaxants centrally acting.
Pharmacological properties:
Tolperisone is a centrally acting muscle relaxant. The mechanism of action is not fully understood. Tolperisone possesses high affinity for neural tissue, reaching the highest concentrations in the brain stem, spinal cord and peripheral nervous system. The main effect of tolperisone is mediated by inhibition of spinal reflex arcs. Probably, this effect together with the elimination of the excitation facilitate downstream paths provides therapeutic effect of tolperisone. The chemical structure similar to the structure of tolperisone lidocaine. Like lidocaine, it has a membrane stabilizing action and reduces electrical excitability of motor neurons, and primary afferent fibers. Tolperisone dose-dependently inhibits the activity of voltage-gated sodium channels. Accordingly, decreasing the amplitude and frequency of action potential. It has been proven inhibitory effect on the voltage-sensitive calcium channels. It is assumed that in addition to its membrane-stabilizing action of tolperisone can also inhibit the release of mediator. Tolperisone possesses certain properties weak alpha-adrenergic antagonists and antimuscarinic effect.
Conditions of supply of pharmacies
Dosing and Administration
Inside, after a meal, without chewing, without opening the capsule with a little water. Bioavailability of tolperisone decreased the fasting state. Dose is selected based on the individual patient’s needs and tolerability. 50 mg 3 times a day, gradually increasing the dose up to 150 mg three times a day. The recommended daily dose of 150-450 mg, divided into 3 parts.
Appearance may differ from that depicted in the picture. There are contraindications. You need to read the manual or consult with a specialist

Additional information

Weight0.100 kg


There are no reviews yet.

Add your review